O'Shaughnessy Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.3M Sell
253,852
-12,793
-5% -$1.14M 0.12% 178
2026
Q1
$19.2M Buy
266,645
+7,265
+3% +$560K 0.1% 230
2025
Q4
$20.6M Buy
259,380
+32,536
+14% +$2.56M 0.11% 199
2025
Q3
$17.1M Buy
226,844
+8,699
+4% +$596K 0.1% 230
2025
Q2
$15M Buy
218,145
+21,337
+11% +$1.4M 0.1% 227
2025
Q1
$13.3M Buy
196,808
+138,710
+239% +$8.3M 0.11% 221
2024
Q4
$2.61M Sell
58,098
-6,432
-10% -$361K 0.02% 578
2024
Q3
$4.35M Buy
64,530
+7,778
+14% +$454K 0.04% 435
2024
Q2
$3.35M Sell
56,752
-29,804
-34% -$1.86M 0.03% 463
2024
Q1
$6.9M Buy
86,556
+22,400
+35% +$1.71M 0.08% 285
2023
Q4
$5.07M Sell
64,156
-56,060
-47% -$3.99M 0.07% 307
2023
Q3
$8.39M Sell
120,216
-303
-0.3% -$21.5K 0.12% 191
2023
Q2
$8.33M Sell
120,519
-1,459
-1% -$104K 0.12% 181
2023
Q1
$9.06M Sell
121,978
-17,305
-12% -$1.45M 0.14% 161
2022
Q4
$13M Sell
139,283
-15,755
-10% -$1.52M 0.21% 131
2022
Q3
$14.8M Buy
155,038
+21,912
+16% +$2.17M 0.28% 102
2022
Q2
$12.3M Buy
133,126
+5,839
+5% +$570K 0.23% 120
2022
Q1
$12.9M Buy
127,287
+63,811
+101% +$6.7M 0.21% 125
2021
Q4
$6.55M Buy
63,476
+39,234
+162% +$3.63M 0.12% 197
2021
Q3
$2.06M Sell
24,242
-472
-2% -$39.5K 0.04% 310
2021
Q2
$2.06M Buy
24,714
+2,791
+13% +$229K 0.04% 306
2021
Q1
$1.65M Buy
21,923
+2,199
+11% +$160K 0.04% 302
2020
Q4
$1.35M Buy
19,724
+7,423
+60% +$483K 0.04% 284
2020
Q3
$719K Buy
12,301
+2,923
+31% +$182K 0.02% 371
2020
Q2
$609K Buy
9,378
+8,266
+743% +$521K 0.02% 361
2020
Q1
$66K Sell
1,112
-200
-15% -$13.4K ﹤0.01% 723
2019
Q4
$97K Buy
1,312
+1,309
+43,633% +$91.9K ﹤0.01% 806
2019
Q3
$0 Hold
3
﹤0.01% 1028
2019
Q2
$0 Sell
3
-235
-99% -$12.7K ﹤0.01% 1021
2019
Q1
$13K Sell
238
-70,331
-100% -$4.34M ﹤0.01% 772
2018
Q4
$4.62M Sell
70,569
-41,808
-37% -$3.12M 0.12% 122
2018
Q3
$8.85M Sell
112,377
-558,149
-83% -$39.9M 0.18% 90
2018
Q2
$43.1M Buy
670,526
+39,416
+6% +$2.6M 0.91% 34
2018
Q1
$39.3M Buy
631,110
+261,524
+71% +$18.8M 0.86% 40
2017
Q4
$26.8M Sell
369,586
-284,583
-44% -$20.7M 0.63% 43
2017
Q3
$53.2M Buy
654,169
+594,164
+990% +$47M 1.24% 23
2017
Q2
$4.83M Buy
+60,005
New +$4.74M 0.11% 128
2016
Q3
Sell
-23,722
Closed -$2.27M 896
2016
Q2
$2.27M Sell
23,722
-5,664
-19% -$564K 0.06% 195
2016
Q1
$3.06M Sell
29,386
-9,556
-25% -$929K 0.08% 162
2015
Q4
$3.81M Buy
38,942
+5,655
+17% +$554K 0.09% 153
2015
Q3
$3.21M Buy
33,287
+27,062
+435% +$2.85M 0.07% 183
2015
Q2
$653K Buy
6,225
+735
+13% +$75.1K 0.01% 355
2015
Q1
$567K Buy
5,490
+5,398
+5,867% +$546K 0.01% 364
2014
Q4
$9K Sell
92
-114
-55% -$10K ﹤0.01% 806
2014
Q3
$16K Buy
206
+2
+1% +$158 ﹤0.01% 714
2014
Q2
$15K Sell
204
-228
-53% -$17.2K ﹤0.01% 722
2014
Q1
$32K Sell
432
-4
-0.9% -$283 ﹤0.01% 660
2013
Q4
$31K Buy
436
+109
+33% +$7K ﹤0.01% 654
2013
Q3
$19K Sell
327
-422
-56% -$25.1K ﹤0.01% 673
2013
Q2
$43K Buy
+749
New +$43.4K ﹤0.01% 610

Other funds holding CVS

O'Shaughnessy Asset Management's CVS Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its CVS Health (CVS) stake by 4.8% in Q2 2026, selling an estimated $1.14M and leaving 253,852 shares worth $26.3M. The position accounts for 0.12% of the portfolio, ranked #178.

O'Shaughnessy Asset Management first reported a position in CVS in Q2 2013 and has held it in 50 quarters since. The position peaked at $53.2M in Q3 2017. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • O'Shaughnessy Asset Management held 253,852 shares of CVS Health worth $26.3M as of Q2 2026.
  • O'Shaughnessy Asset Management sold 12,793 CVS Health shares in Q2 2026, an estimated $1.14M.
  • CVS Health made up 0.12% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #178 holding.
  • O'Shaughnessy Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 50 quarters since.
  • O'Shaughnessy Asset Management's CVS Health position peaked at $53.2M in Q3 2017.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.